Europe Veterinary Antibiotics Market Size- By Animal Type, By Drug Class, By Dosage Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
Europe Veterinary Antibiotics Market Introduction and Overview
According to SPER Market Research, ‘Europe Veterinary Antibiotics Market Size- By Animal Type, By Drug Class, By Dosage Form – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ the Europe Veterinary Antibiotics Market is estimated to reach USD 1.53 billion by 2034 with a CAGR of 2.57%.
Veterinary antibiotics are drugs used to treat, prevent, and control bacterial infections in animals, including livestock, poultry, and pets. They are vital for maintaining animal health, ensuring the productivity of food-producing animals, and reducing the risk of zoonotic diseases—those transmissible to humans. These antibiotics come in various forms, such as oral solutions, injections, and topical treatments, depending on the species and condition.
Restraints:
The European veterinary antibiotics market faces several challenges that may affect its growth. A key concern is antibiotic resistance, prompting stricter regulations that limit antibiotic use in animals. While these measures protect public health, they restrict routine use and demand. There is also increased emphasis on alternative disease prevention methods like better hygiene and vaccination, which reduce antibiotic reliance.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Animal Type, By Drug Class, By Dosage Form
Regions covered
France, Germany, Italy, Spain, United Kingdom Rest of Europe
Companies Covered
Merck & Co., Inc., Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Vetoquinol S.A, Virbac, Calier, Bimeda, Inc., Prodivet Pharmaceuticals SA/NV.
Europe Veterinary Antibiotics Market Segmentation:
By Animal Type: Based on the Animal Type, Europe Veterinary Antibiotics Market is segmented as; Pigs, Cattle, Sheep & Goats, Poultry, Others
By Drug Class: Based on the Drug Class, Europe Veterinary Antibiotics Market is segmented as; Tetracyclines, Penicillins, Sulfonamides, Macrolides, Trimethoprim, Lincosamides, Polymyxins, Aminoglycosides, Fluoroquinolones, Pleuromutilins, Other Drug Class.
By Dosage Form: Based on the Dosage Form, Europe Veterinary Antibiotics Market is segmented as; Oral Powder, Oral Solution, Injection, Other Dosage Forms.
By Region: This research also includes data for France, Germany, Italy, Spain, United Kingdom Rest of Europe
According to SPER Market Research, ‘Europe Veterinary Antibiotics Market Size- By Animal Type, By Drug Class, By Dosage Form – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ the Europe Veterinary Antibiotics Market is estimated to reach USD 1.53 billion by 2034 with a CAGR of 2.57%.
Veterinary antibiotics are drugs used to treat, prevent, and control bacterial infections in animals, including livestock, poultry, and pets. They are vital for maintaining animal health, ensuring the productivity of food-producing animals, and reducing the risk of zoonotic diseases—those transmissible to humans. These antibiotics come in various forms, such as oral solutions, injections, and topical treatments, depending on the species and condition.
Restraints:
The European veterinary antibiotics market faces several challenges that may affect its growth. A key concern is antibiotic resistance, prompting stricter regulations that limit antibiotic use in animals. While these measures protect public health, they restrict routine use and demand. There is also increased emphasis on alternative disease prevention methods like better hygiene and vaccination, which reduce antibiotic reliance.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Animal Type, By Drug Class, By Dosage Form
Regions covered
France, Germany, Italy, Spain, United Kingdom Rest of Europe
Companies Covered
Merck & Co., Inc., Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Vetoquinol S.A, Virbac, Calier, Bimeda, Inc., Prodivet Pharmaceuticals SA/NV.
Europe Veterinary Antibiotics Market Segmentation:
By Animal Type: Based on the Animal Type, Europe Veterinary Antibiotics Market is segmented as; Pigs, Cattle, Sheep & Goats, Poultry, Others
By Drug Class: Based on the Drug Class, Europe Veterinary Antibiotics Market is segmented as; Tetracyclines, Penicillins, Sulfonamides, Macrolides, Trimethoprim, Lincosamides, Polymyxins, Aminoglycosides, Fluoroquinolones, Pleuromutilins, Other Drug Class.
By Dosage Form: Based on the Dosage Form, Europe Veterinary Antibiotics Market is segmented as; Oral Powder, Oral Solution, Injection, Other Dosage Forms.
By Region: This research also includes data for France, Germany, Italy, Spain, United Kingdom Rest of Europe
Table of Contents
159 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Europe Veterinary Antibiotics Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Veterinary Antibiotics Market
- 7. Europe Veterinary Antibiotics Market, By Animal Type (USD Million) 2021-2034
- 7.1. Pigs
- 7.2. Cattle
- 7.3. Sheep & Goats
- 7.4. Poultry
- 7.5. Others
- 8. Europe Veterinary Antibiotics Market, By Drug Class (USD Million) 2021-2034
- 8.1. Tetracyclines
- 8.2. Penicillins
- 8.3. Sulfonamides
- 8.4. Macrolides
- 8.5. Trimethoprim
- 8.6. Lincosamides
- 8.7. Polymyxins
- 8.8. Aminoglycosides
- 8.9. Fluoroquinolones
- 8.10. Pleuromutilins
- 8.11. Other Drug Class
- 9. Europe Veterinary Antibiotics Market, By Dosage Form (USD Million) 2021-2034
- 9.1. Oral Powder
- 9.2. Oral Solution
- 9.3. Injection
- 9.4. Other Dosage Forms
- 10. Europe Veterinary Antibiotics Market, (USD Million) 2021-2034
- 10.1. Europe Veterinary Antibiotics Market Size and Market Share
- 11. Europe Veterinary Antibiotics Market, By Region, (USD Million) 2021-2034
- 11.1. France
- 11.2. Germany
- 11.3. Italy
- 11.4. Spain
- 11.5. United Kingdom
- 11.6. Rest of Europe
- 12. Company Profile
- 12.1. Merck & Co., Inc.
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. Ceva
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Zoetis
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Boehringer Ingelheim GmbH
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Elanco
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Vetoquinol S. A
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Virbac
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Calier
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Bimeda, Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Prodivet Pharmaceuticals SA/NV
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
- 13. Conclusion
- 14. List of Abbreviations
- 15. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.